- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CompuMed claims digital advance
Bone densitometry firm CompuMed announced last week that it has successfully acquired images using both dual-energy x-ray absorptiometry and amorphous silicon x-ray detectors. The Manhattan Beach, CA, firm believes that being able to acquire such images
Bone densitometry firm CompuMed announced last week that it has successfully acquired images using both dual-energy x-ray absorptiometry and amorphous silicon x-ray detectors. The Manhattan Beach, CA, firm believes that being able to acquire such images will help the company in its development of Digital OsteoView 2000, a device designed to detect both osteoporosis and arthritis.
CompuMed scientists working with researchers at the University of Massachusetts used amorphous silicon flat-panel detectors licensed from Varian Associates, with whom CompuMed has an OEM agreement (SCAN 1/8/97). CompuMed plans to file for 510(k) clearance for Digital OsteoView 2000 later this year.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
